Drug Screening and Toxicity Assessment

The drug discovery process depends crucially on Drug Screening and Toxicity Assessment. By applying various testing procedures the process determines promising drug candidates and assesses their safety levels which establishes a trustworthy foundation for future clinical trials. Drug screening focuses on finding compounds with desired biological effects while toxicity assessment seeks to evaluate the possible dangers these substances pose to biological systems including target organ toxicity and dose-response relationships. Identifying and removing toxic compounds early on reduces both the risks and development costs associated with new drugs.